The Medical Devices (Northern Ireland Protocol) Regulations 2021

Overview

The Medical Devices (Northern Ireland Protocol) Regulations 2021 amend UK medical devices legislation to reflect the regulatory position of Northern Ireland under the EU-UK Withdrawal Agreement (Windsor Framework/NI Protocol). The Regulations ensure that EU medical device rules continue to apply in Northern Ireland while establishing distinct arrangements for Great Britain. They introduce requirements relating to conformity assessment, product marking (including CE and UKNI markings), regulatory oversight, and market access conditions for medical devices placed on the Northern Ireland market.

Following the UK’s exit from the European Union, Northern Ireland remains aligned with certain EU rules for goods, including medical devices. These Regulations amend the Medical Devices Regulations 2002 to give effect to that arrangement. They ensure that EU regulatory frameworks (the Medical Devices Regulation (EU) 2017/745 (MDR) and In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR)) continue to apply in Northern Ireland, while also introducing UK-specific provisions for oversight and marking. The legislation is critical for manufacturers, importers and distributors placing medical devices on the Northern Ireland market.

Benefits of compliance:

• Enables lawful placement of medical devices on the Northern Ireland market.
• Ensures continued access to EU and NI markets where applicable.
• Reduces risk of regulatory enforcement and product withdrawal.
• Supports ISO 13485 (medical device quality management systems).
• Supports ISO 9001 quality assurance and product compliance.
• Enhances product safety, traceability and regulatory oversight.
• Strengthens documentation and conformity assessment processes.
• Improves market credibility and regulatory acceptance.